This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 432
From Proteopedia
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Protein complex with cancer drug Alecensa-Alectinib (4uxl)
by Laura Feeley, Katie Kwan, Daniel Peters, Ishtiaq Rafiyu, Luke Ruksnaitis
Student Projects for UMass Chemistry 423 Spring 2016
Introduction
(Laura) Background -types of cancer it is used to treat -How it works-Inhibits ALK (Anaplastic lymphoma kinase) -insert green scene of protein bound to ligand, linking on the word Inhibits -or possible green scene on ALK kinase itself
|
This is a sample scene created with SAT to by Group, and another to make of the protein.
Overall Structure
| |||||||||||
